Pink Sheet is part of Informa PLC

This site is operated by a business or businesses owned by Informa PLC and all copyright resides with them. Informa PLC’s registered office is 5 Howick Place, London SW1P 1WG. Registered in England and Wales. Number 8860726.

This copy is for your personal, non-commercial use. For high-quality copies or electronic reprints for distribution to colleagues or customers, please call +44 (0) 20 3377 3183

Printed By

UsernamePublicRestriction
UsernamePublicRestriction

UK antihistamines

This article was originally published in The Tan Sheet

Executive Summary

Medicines Control Agency proposes lifting pharmacy pack size restrictions for loratadine (Schering-Plough's Claritin) and cetirizine (Zyrtec, marketed by UCB Pharma in UK) in an Aug. 24 "consultation letter" amendment. Antihistamines currently are sold in packs containing "not more than seven tablets." Responses to MCA's June 15 proposal to reclassify the two drugs to "general sales list," which permits distribution in non-pharmacy outlets, suggested the additional change (1"The Tan Sheet" July 2, p. 3). MCA will accept comments through Oct. 18
Advertisement

Topics

Advertisement
UsernamePublicRestriction

Register

PS092993

Ask The Analyst

Please Note: You can also Click below Link for Ask the Analyst
Ask The Analyst

Your question has been successfully sent to the email address below and we will get back as soon as possible. my@email.address.

All fields are required.

Please make sure all fields are completed.

Please make sure you have filled out all fields

Please make sure you have filled out all fields

Please enter a valid e-mail address

Please enter a valid Phone Number

Ask your question to our analysts

Cancel